Moneycontrol PRO
HomeNewsWorldReinfections three times more likely with Omicron Covid-19 variant: Study

Reinfections three times more likely with Omicron Covid-19 variant: Study

The findings, based on data collected by the country's health system, provides the first epidemiological evidence about Omicron's ability to evade immunity from prior infection.

December 04, 2021 / 10:15 IST

A preliminary study by South African scientists published Thursday suggests the Omicron variant is three times more likely to cause reinfections compared to the Delta or Beta strains.

The findings, based on data collected by the country's health system, provides the first epidemiological evidence about Omicron's ability to evade immunity from prior infection.

The paper was uploaded on a medical preprint server and has not yet been peer-reviewed.

There were 35,670 suspected reinfections among 2.8 million individuals with positive tests until November 27. Cases were considered reinfections if they tested positive 90 days apart.

"Recent reinfections have occurred in individuals whose primary infections occurred across all three waves, with the most having their primary infection in the Delta wave," tweeted Juliet Pulliam, director of the South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Pulliam cautioned that the authors did not have information about the individuals' vaccination status and therefore could not assess to what extent Omicron evades vaccine-induced immunity. The researchers plan to study this next.

"Data are also urgently needed on disease severity associated with Omicron infection, including in individuals with a history of prior infection," she said.

Earlier, top South African scientist Anne von Gottberg, an expert at the National Institute for Communicable Diseases, forecast a surge in cases but said authorities expected vaccines would still be effective against severe outcomes.

"We believe the number of cases will increase exponentially in all provinces of the country," she said in a news conference with the World Health Organization's Africa region.

"We believe that vaccines will still however protect against severe disease," she added.

"Vaccines have always held out to protect against serious disease, hospitalisations and death."

WHO experts reiterated calls for a rethink on travel bans against southern Africa, given that Omicron had now been reported in nearly two dozen countries and its source remained unclear.

"South Africa and Botswana detected the variant. We don't know where the origin of this could have been," said specialist Ambrose Talisuna. "To punish people who are just detecting or reporting... is unfair."

In mid-November, South Africa was reporting about 300 cases a day. On Wednesday the country reported 8,561 new cases, up from 4,373 the day before and 2,273 on Monday.

AFP
first published: Dec 3, 2021 09:06 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347